Noel Wardle and Peter Byrd write for Chemist and Druggist on the possible next steps for Amazon Pharmacy
Noel Wardle and Peter Byrd have written for Chemist and Druggist on the possible next steps for Amazon Pharmacy. Read more below.
-
In the Press
Our thinking
-
-
-
-
-
Charles Russell Speechlys advises Integrum Group on its acquisition of two UK care homes
David Coates
News
-
-
UAE CCL Reforms: Introducing Multi-Class Shares, Drag / Tag Rights, Deadlock Solutions and Governance Continuity
Mo Nawash
Quick Reads
-
Dewdney Drew writes for the AI Journal on AI actors and the legal hurdles facing a digital revolution
Dewdney William Drew
In the Press
-
Navigating Regulation (EU) 2019/880: implementation in Italy and competent authorities for the New European Framework for Importing Works of Arts
Maria Cristiana Felisi
Quick Reads
-
World Intellectual Property Review quotes Dewdney William Drew on the Getty Images vs Stability AI decision
Dewdney William Drew
In the Press
-
Charles Russell Speechlys further expands Intellectual Property offering with new Partner hire in London
Stewart Hey
News
-
Facilitated adoption in Switzerland for children born by ART or surrogacy?
Catherine Merkt
Quick Reads
-
AI and Intellectual Property: Ownership, Infringement and Reform
Caroline Young
Insights
-
The Daily Telegraph quotes Nicola Saccardo on our Italian practice and wealthy individuals relocating to Italy
Nicola Saccardo
In the Press
-
Charles Russell Speechlys advises Kinly Care on the acquisition of Alpha Care group of homes.
David Coates
In the Press
-
Charles Russell Speechlys adds Corporate, Fintech, IP and Art Law team in Milan with Arrival of Annapaola Negri-Clementi and Team
Nicola Saccardo
News
-
Licence to sponsor… revoked – record numbers lose right to hire migrant workers
Emily McPartland
Quick Reads
-
Exiting an investment - how Single Family Offices can prepare a company for sale
Mike Barrington
Insights
-
-
Copyright Hell: Sketchy evidence is better than no evidence
Dewdney William Drew
Insights